EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Benefits, Barriers and Determinants of Clinical Pathway Use in Germany, Austria and Switzerland. A pilot study

Elisabeth Noehammer iD, Matthias Ponweiser, Tobias Romeyke, Florian Eibinger

Health Services Management Research · 2023-05 · 36 (2) · 119-126

DOI: 10.1177/09514848221107485 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Services Management Research, online erschienen am 30.06.2022. Verfasst von Elisabeth Noehammer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department for Public Health, Health Services Research and HTA, UMIT - Private University for Health Sciences, Medical Informatics and Technology, Au…. Hauptthemen laut MEDLINE: Critical Pathways. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Tiroler Wissenschaftsfonds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Performance-oriented financing of healthcare aims at demand-based and efficient resource allocation. Often, clinical pathways (CPs) are introduced in this context.

Purpose

For CP success (a) the degree of utilization of and divergence, (b) cost effects and (c) health professionals’ acceptance rate of and satisfaction are relevant. There are gaps in research regarding these issues in general, and more specifically in the German speaking part of Europe. Methodology/Approach Employing a two-stage mixed-methods pilot study, we studied (a) and (b) quantitatively in Germany, Austria, and Switzerland, and (c) qualitatively in Germany and Austria.

Results

Many hospitals already implemented CPs, but the utilization varies. They are expected to yield middle-range savings, but intangible benefits are more important. In general, employees are in favor of CPs, but several conditions need to be met, e.g. adaptability to local requirements.

Conclusion

Linking the results to the Consolidated Framework for Implementation Research showed many criteria are covered, which might lead to the positive evaluations, but also highlights the complexity of the intervention. Practice Implication As enhanced acceptance rates are expected to lead to higher benefits and vice versa, management team should safeguard employee participation and perceived benefits in all phases of the CP cycle.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Critical PathwaysHumansSwitzerlandAustriaPilot ProjectsGermany

Stichwörter der Autor:innen

Clinical guidelinesEmployeesEuropeEvaluationGermanyImplementation

Autor:innen und Institutionen

  • Department for Public Health, Health Services Research and HTA, UMIT - Private University for Health Sciences, Medical Informatics and Technology, Austria.

ORCID-Profile: Elisabeth Noehammer

Förderung

  • Tiroler Wissenschaftsfonds

Zitieren

APA

Noehammer, E., Ponweiser, M., Romeyke, T., & Eibinger, F. (2023). Benefits, Barriers and Determinants of Clinical Pathway Use in Germany, Austria and Switzerland. A pilot study. Health Services Management Research, 36(2), 119-126. https://doi.org/10.1177/09514848221107485

Vancouver

Noehammer E, Ponweiser M, Romeyke T, Eibinger F. Benefits, Barriers and Determinants of Clinical Pathway Use in Germany, Austria and Switzerland. A pilot study. Health Services Management Research. 2023;36(2):119-126. doi:10.1177/09514848221107485

BibTeX
@article{Noehammer2023,
  author = {Noehammer, Elisabeth and Ponweiser, Matthias and Romeyke, Tobias and Eibinger, Florian},
  title = {Benefits, Barriers and Determinants of Clinical Pathway Use in Germany, Austria and Switzerland. A pilot study},
  journal = {Health Services Management Research},
  year = {2023},
  volume = {36},
  number = {2},
  pages = {119--126},
  doi = {10.1177/09514848221107485}
}
Kostenlos starten →